{
    "Trade/Device Name(s)": [
        "directCHECK\u00ae Whole Blood Control for HEMOCHRON\u00ae ACT+ assay",
        "directCHECK \u212c Whole Blood Control for HEMOCHRON\u00ae ACT-LR assay",
        "directCHECK\u00ae for Hemochron Jr. Microcoagulation Systems ACT+ test cuvette",
        "directCHECK \u212c for Hemochron Jr. Microcoagulation Systems ACTLR test cuvette",
        "directCHECK \u2297 Whole Blood ACT+",
        "directCHECK \u2297 Whole Blood ACT-LR"
    ],
    "Submitter Information": "International Technidyne Corporation",
    "510(k) Number": "K120977",
    "Predicate Device Reference 510(k) Number(s)": [
        "K960749",
        "K941007"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGN"
    ],
    "Summary Letter Date": "June 26, 2013",
    "Summary Letter Received Date": "June 27, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Multipurpose system for in vitro coagulation"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "ACT-LR",
        "ACT+"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [
        "Glass ampoule with liquid diluent assembly"
    ],
    "Instrument(s)/Platform(s)": [
        "HEMOCHRON\u00ae Jr. Signature+",
        "HEMOCHRON\u00ae Signature Elite"
    ],
    "Method(s)/Technology(ies)": [
        "Lyophilized whole blood control",
        "In vitro diagnostic coagulation quality control"
    ],
    "Methodologies": [
        "Assayed lyophilized whole blood control material"
    ],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for directCHECK Whole Blood Controls for use as quality control in HEMOCHRON ACT+ and ACT-LR coagulation assays on HEMOCHRON Jr. Signature+ and Signature Elite instruments",
    "Indications for Use Summary": "Assayed lyophilized whole blood controls intended for quality control of quantitative coagulation tests: HEMOCHRON ACT+ or ACT-LR assays on HEMOCHRON Jr. Signature+ and Signature Elite instruments.",
    "fda_folder": "Hematology"
}